Regulatory Mechanisms Underlying Endosomal Targeting of SORL1

Principal Investigator
Olav Andersen, PhD
Max Delbrück Center for Molecular Medicine
Berlin, Germany
About the Research Project
Program
Award Type
Standard
Award Amount
$85,000
Active Dates
January 01, 2025 - December 31, 2026
Grant ID
CA2025001
Acknowledgement
Goals
The goal is to identify novel mechanisms that regulate sorting of SORL1 to and from the endo-lysosomal network.
Unique and Innovative
Current knowledge on the intracellular trafficking itinerary of SORL1 is limited to studies from common cell lines, and only few details on its sorting steps in human neurons. Here we want to expand our knowledge focusing also on SORL1 binding partners and sorting steps in neurons as well as starting to address its trafficking pathway also in glia cells, including how on/off-signals can be regulated by phosphorylation of key residues within SORL1 sorting signals.
Foreseeable Benefits
As SORL1 is a major contributing factor for familial Alzheimer’s disease, an improved understanding of its biology related to disease mechanisms holds the promise for a better understanding of disease etiology for patients suffering from defects in the SORL1-trafficking pathway. This can potentially open for novel therapeutic strategies of benefits for the public.
Related Grants
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Current Organization
Douglas Research Centre
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Current Organization
Douglas Research Centre
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Current Organization
University College London (UK)
Alzheimer's Disease Research
The Role of the Brain Vascular-Immune Processes in Alzheimer’s
Active Dates
July 01, 2024 - June 30, 2026
Principal Investigator
Julie Ottoy, PhD
Current Organization
Sunnybrook Research Institute
The Role of the Brain Vascular-Immune Processes in Alzheimer’s
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Julie Ottoy, PhD
Current Organization
Sunnybrook Research Institute